Evidence map›Paper›PMID 39519699›Full record

ArticleMolecules (Basel, Switzerland)2024

Design, Synthesis, Molecular Docking, and ADME-Tox Investigations of Imidazo[1,2-a]Pyrimidines Derivatives as Antimicrobial Agents.

Djamila Benzenine, Ismail Daoud, Nadia Aissaoui, Zahira Kibou, Julio A Seijas, M Pilar Vázquez-Tato, Chewki Ziani-Cherif, Lahcen Belarbi, Noureddine Choukchou-Braham

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Djamila BenzenineLaboratoire de Catalyse et Synthèse en Chimie Organique, Faculté des Sciences, Université de Tlemcen, BP 119, Tlemcen 13000, Algeria.
Ismail DaoudDepartment of Matter Sciences, University Mohamed Khider, BP 145 RP, Biskra 07000, Algeria.
Nadia AissaouiLaboratory of the Sustainable Management of Natural Resources in Arid and Semi-Arid Areas, Institute of Sciences, University Center of Naama, BP 66, Naama 45000, Algeria.
Zahira KibouLaboratoire de Catalyse et Synthèse en Chimie Organique, Faculté des Sciences, Université de Tlemcen, BP 119, Tlemcen 13000, Algeria.
Julio A SeijasDepartamento de Química Orgánica, Facultad de Ciencias, Universidad de Santiago de Compostela, Avda. Alfonso X El Sabio s/n, 27002 Lugo, Spain.ORCID 0000-0002-5201-8873
M Pilar Vázquez-TatoDepartamento de Química Orgánica, Facultad de Ciencias, Universidad de Santiago de Compostela, Avda. Alfonso X El Sabio s/n, 27002 Lugo, Spain.ORCID 0000-0003-3254-710X
Chewki Ziani-CherifLaboratoire de Catalyse et Synthèse en Chimie Organique, Faculté des Sciences, Université de Tlemcen, BP 119, Tlemcen 13000, Algeria.
Lahcen BelarbiFaculté des Sciences et de la Technologie, Université de Ain Témouchent, BP 284, Ain Témouchent 46000, Algeria.
Noureddine Choukchou-BrahamLaboratoire de Catalyse et Synthèse en Chimie Organique, Faculté des Sciences, Université de Tlemcen, BP 119, Tlemcen 13000, Algeria.ORCID 0000-0002-3640-8652

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A convenient and effective synthesis of imidazo[1,2-

Indexed as

Anti-Infective AgentsDrug DesignMicrobial Sensitivity TestsMolecular Docking SimulationPyrimidinesFungiGram-Negative BacteriaGram-Positive BacteriaImidazolesMolecular StructureStructure-Activity RelationshipAnti-Infective AgentsImidazolesPyrimidinesAl2O3 catalystantimicrobial activityimidazo[1,2-a]pyrimidinein silico studymicrowavesolvent free

Identifiers

PMID39519699
PMCPMC11547262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.